Peer Review History

Original SubmissionAugust 22, 2024
Decision Letter - Flora De Conto, Editor

PONE-D-24-34411Networks of Care for Optimizing Community Health Programs in Ethiopia: Enhancing Linkages and Coordination within Primary Health CarePLOS ONE

Dear Dr. Tiruneh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:In order to make the article more compliant with scientific criteria, I suggest eliminating the italicized citations in the text of subjects who, moreover, are not clearly identifiable. Alternatively, they must be reported according to rigorous and standardized criteria.

==============================

Please submit your revised manuscript by Nov 22 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Flora De Conto, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“We would like to thank the Bill & Melinda Gates Foundation for their generous funding and guidance throughout the project design and implementation”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The project is funded by the Bill & Melinda Gates Foundation and implemented through a collaborative consortium of Amref Health Africa and JSI. The funder has no role in the interpretation and implications of the content in this paper. This responsibility lies solely with the authors.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that your Data Availability Statement is currently as follows: [All data used for this analysis is included in this report.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

5. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article is comprehensive and provides detailed insights into the topic, but some sections could be streamlined for clarity.

1. The section detailing the Networks of Care (NOC) is overly long and could benefit from conciseness. Summarizing key elements of NOC—such as its role in improving coordination, resource sharing, and maternal care outcomes—would make the manuscript more accessible without losing important information.

2. The mention of the RE-AIM framework feels underdeveloped. If the authors are not applying it fully by reporting on key dimensions like reach, adoption, implementation, and maintenance, it may be better to omit the framework from the methodology or expand its use and provide relevant data for each component.

3. Fidelity should be clearly defined. Currently, it is discussed without specifying what components of the intervention were monitored for adherence, or how deviations were measured. A more structured discussion on how fidelity was evaluated would improve the rigor of the paper.

4. A summary table showing key indicators and the corresponding data collection methods would be helpful for readers. This would clarify how the study measured outcomes and tracked progress over time.

5. The key informant interview methodology was very briefly mentioned ("Qualitative data from key informant interviews were transcribed, coded, and thematically analyzed using Atlas.ti"). I suggest following a standard checklist, such as COREQ, to provide more detailed information on qualitative data collection, including sampling, interview guides, and the coding process.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

A point-by-point response to reviews

Dear Editor,

We, the authors, would like to express our gratitude to the reviewers and editors of PLOS ONE Journal for their valuable comments, which we believe have significantly strengthened our paper. Below, we provide point-by-point responses to each comments and suggestions. We have also reviewed the manuscript to ensure that it conforms to the journal's style.

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

Response: We reviewed to ensure that this version of the manuscript conforms to the journal style.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

Response: Thank you. The ethics statement has been revised to include details on consent. The following sentences are now part of the revised version (page 12 lines 214-220):

“For the retrospective service statistics from medical records, data were collected in monthly aggregates and fully anonymized prior to access. The IRB waived the requirement for client informed consent; however, we obtained consent from facility directors. Informed written consent was also secured from key informants for qualitative interviews. All information obtained from informants was de-identified before analysis, and we maintained strict confidentiality throughout all stages of the study. “

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“We would like to thank the Bill & Melinda Gates Foundation for their generous funding and guidance throughout the project design and implementation”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The project is funded by the Bill & Melinda Gates Foundation and implemented through a collaborative consortium of Amref Health Africa and JSI. The funder has no role in the interpretation and implications of the content in this paper. This responsibility lies solely with the authors.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response: Thanks. We have removed the funding-related text from the manuscript. The funding statement contains all necessary declarations and does not require any updates.

4. We note that your Data Availability Statement is currently as follows: [All data used for this analysis is included in this report.]

Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data:

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis.

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

Response: The qualitative KII guide and the data used for this analysis have been included as Supplementary Information in S4 and S6, respectively.

5. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Fig share or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

Response: Thanks. Figure 5 is provided instead (See page 21, lines 408-409)

Review Comments to the Author

Reviewer #1: The article is comprehensive and provides detailed insights into the topic, but some sections could be streamlined for clarity.

1. The section detailing the Networks of Care (NOC) is overly long and could benefit from conciseness. Summarizing key elements of NOC—such as its role in improving coordination, resource sharing, and maternal care outcomes—would make the manuscript more accessible without losing important information.

Response: Thank you for your valuable comment. In this version, we have significantly trimmed this section without losing key information and added S2 Table as supplementary information.

2. The mention of the RE-AIM framework feels underdeveloped. If the authors are not applying it fully by reporting on key dimensions like reach, adoption, implementation, and maintenance, it may be better to omit the framework from the methodology or expand its use and provide relevant data for each component.

Response: Comment acknowledged. Since we did not report on all dimensions of the RE-AIM framework, we have removed it in this version.

3. Fidelity should be clearly defined. Currently, it is discussed without specifying what components of the intervention were monitored for adherence, or how deviations were measured. A more structured discussion on how fidelity was evaluated would improve the rigor of the paper.

Response: Comment acknowledged. In the measurement section, we have now defined fidelity and outlined how we measured it, see Table 1 (page 10, line 188)

4. A summary table showing key indicators and the corresponding data collection methods would be helpful for readers. This would clarify how the study measured outcomes and tracked progress over time.

Response: Comment well taken and Table 1 presents the key indicators measured, along with their definitions and data sources (page 10, line 183)

5. The key informant interview methodology was very briefly mentioned ("Qualitative data from key informant interviews were transcribed, coded, and thematically analyzed using Atlas.ti"). I suggest following a standard checklist, such as COREQ, to provide more detailed information on qualitative data collection, including sampling, interview guides, and the coding process.

Response: Details of the KII data collection, the tool used (included as S4), and the analysis are now included.

The following paragraph is included in the data collection section (See page 9, lines 177-184).

“Qualitative data were collected in March 2024 by the project M&E and program managers using an interview guide with open-ended and probing questions to gather insights from program implementers. The main topics of discussion included the differences between NOC and existing linkages, participatory and contextualized design, roles and responsibilities of network members, care coordination and communication, operational impact on PHC and HEP, collaboration and oversight, adherence to standards and quality improvement, monitoring and evaluation mechanisms, support systems and resource sharing, barriers and facilitators, unintended consequences, and areas for improvement (S6 File). Interviews were conducted at convenient locations within the participants' work environment.”

The Analysis section is also revised as follows (see page 12, lines 202-207);

“All interviews were audio-taped with the consent of the study participants and the records were transcribed verbatim by the project M&E team. The qualitative data from KIIs were transcribed, coded, and thematically analyzed using Atlas.ti. Priori codes were generated from the interview guide. Reports of quotations, themes, and patterns of interrelationships between the themes were identified. and quantitative data were integrated during both the presentation and interpretation stages.”

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Flora De Conto, Editor

PONE-D-24-34411R1Networks of Care for Optimizing Primary Health Care Service Delivery in Ethiopia: Enhancing Relational Linkages and Care CoordinationPLOS ONE

Dear Dr. Tiruneh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has been implemented compared to the first version. However, you must complete the review in accordance with the guidance provided by the reviewers. Furthermore, it is necessary to explain the changes that have occurred in the list of authors, since a new author has been added and to certify that all the authors of the manuscript are aware of and in agreement with them, in compliance with the policy of the Journal PLOS ONE.

Please submit your revised manuscript by Dec 26 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Flora De Conto, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

********** 

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

********** 

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

********** 

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for the revision. The manuscript has improved in many ways. However, I have included my responses and a few additional comments below (in purple).

Overall comments

Previous responses and comments

1. Thank you for the revision. Table S2 provides an adequate overview of the framework.

2. "The mention of the RE-AIM framework feels underdeveloped. If the authors are not applying it fully by reporting on key dimensions like reach, adoption, implementation, and maintenance, it may be better to omit the framework from the methodology or expand its use and provide relevant data for each component.

Response: Comment acknowledged. Since we did not report on all dimensions of the RE-AIM framework, we have removed it in this version."

Further comments:

In my opinion, if the authors do not expand on their use of the RE-AIM framework (specifying which components guided which indicators and acknowledging any components omitted due to limitations), they should consider mentioning other frameworks that may better suit the manuscript. Otherwise, readers may be confused about how each indicator was selected for analysis.

3. Fidelity should be clearly defined. Currently, it is discussed without specifying what

components of the intervention were monitored for adherence, or how deviations were

measured. A more structured discussion on how fidelity was evaluated would improve

the rigor of the paper.

Response: Comment acknowledged. In the measurement section, we have now

defined fidelity and outlined how we measured it, see Table 1 (page 10, line 188)

Further comments:

Thank you for defining fidelity. However, in line with the previous comment, the presentation of other indicators is confusing, as they don’t seem to clearly adhere to any specific framework.

For example, in the results section of the main text, the authors briefly mention fidelity with the statement: “Fidelity: A sizable progress in NoCs implementation fidelity was achieved.” Then, under the Fidelity subsection, functionality is reported instead: “The NoCs functionality score improved from 56% to 89% in agrarian settings and from 38% to 60% in pastoral settings (Fig 2). Improvements included enhanced coordination, standardized referral practices, and increased resource sharing among facilities. Coaching and mentorship strengthened at primary care levels, improving efficiency, access, and quality of care.”

This is confusing because the authors previously defined functionality as a separate indicator. Following a specific implementation evaluation framework (such as the RE-AIM framework or the MRC Process Evaluation Framework, https://pubmed.ncbi.nlm.nih.gov/25791983/) might clarify the structure and interpretation.

4. “A summary table showing key indicators and the corresponding data collection

methods would be helpful for readers. This would clarify how the study measured

outcomes and tracked progress over time.

Response: Comment well taken and Table 1 presents the key indicators measured,

along with their definitions and data sources (page 10, line 183)”.

Further comments: See comments above.

Additional comments

1. Please avoid overusing abbreviations, as it can make the text difficult to understand. For example, "QI" should be written in full.

2. Results (abstract)

“Results: The NoCs approach has significantly strengthened both administrative and technical connections, while enhancing relational linkages, multi-level collaboration, and bidirectional communication. This has fostered trust, improved care coordination, boosted primary health care performance, and increased health service utilization within woreda health systems. The Interrupted time series analysis indicated that the rate of ANC 8+ visits was 29.8% per month higher than expected without the NoCs strategy (Coef: 2.39; p-value < 0.01) and an 18.4% increase in obstetric complications managed (Coef: 1.71; p-value 36 = 0.050), with a 43% overall increase. Perinatal mortality decreased by 34%, from 31.3 to 20.1 per 1,000 births [t-test: 2.12; p-value: 0.040)].”

Could you clarify the definitions and distinctions between “administrative connections,” “technical connections,” “relational linkages,” “multi-level collaboration,” and “bidirectional communication”?

The results section in the main text reports different indicators than these terms. Could you explain the reason for this discrepancy? Furthermore, why does the abstract use a different format, such as “Implementation fidelity, challenges, and adaptations,” “Enhanced bidirectional linkages,” “Optimized HEP and improved performance and efficiency of the PHC system,” and “Improved utilization, quality, and continuity of care”?

3. Discussions

“…Previous studies underscore that involving communities in these networks and quality improvement efforts significantly boosts maternal health program effectiveness. By engaging community members, local leaders, and stakeholders in service design, implementation, and evaluation, programs become more accessible, culturally sensitive, and widely utilized. Initiatives like participatory learning groups, community health committees, and training for health workers increase antenatal visits, skilled birth attendance, and postnatal care, ultimately lowering maternal and neonatal mortality rates [22-24]. These engaged networks build trust between health care providers and communities, ensuring interventions meet local needs sustainably.”

This section would benefit from additional references. For example, the statement “…Previous studies underscore that involving communities in these networks and quality improvement efforts significantly boosts maternal health program effectiveness” should be followed by citations that demonstrate the effectiveness of “involving communities in these networks…”

Additionally, the discussion section appears to emphasize the importance of the NOC framework without comparing other aspects of the research, such as fidelity, functionality, or the evaluation methodology, with existing literature. Please consider including these comparisons.

4. Please provide the study’s limitations.

5. Please provide necessary information about the shared data in Supplementary #6.csv (e.g., brief descriptions, data dictionary).

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: review NOC.docx
Revision 2

A point-by-point response to reviews

Dear Editor,

We, the authors, would like to express our gratitude to the reviewers and editors of PLOS ONE Journal for their valuable comments, which we believe have significantly strengthened our paper. Below, we provide point-by-point responses to each comment and suggestions in red font. We have also reviewed the manuscript to ensure that it conforms to the journal's style.

Editor comment

The manuscript has been implemented compared to the first version. However, you must complete the review in accordance with the guidance provided by the reviewers. Furthermore, it is necessary to explain the changes that have occurred in the list of authors, since a new author has been added and to certify that all the authors of the manuscript are aware of and in agreement with them, in compliance with the policy of the Journal PLOS ONE.

Response: Thank you. We have carefully addressed all the feedback provided by the reviewer in this version. Additionally, including a new author has been communicated to all contributors. We inadvertently omitted his name from the author list in the initial submission. However, he contributed substantially to the manuscript, including project design, data acquisition, conceptualization, and review.

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response: The reference lists have been reviewed, and minor corrections have been made to the format

Reviewers' comments:

Reviewer #1: Thank you for the revision. The manuscript has improved in many ways. However, I have included my responses and a few additional comments below (in purple).

Response: Thank you for the valuable comments, which have been essential for enhancing the scientific rigor of this manuscript. We have carefully addressed all feedback in this version.

Overall comments

Previous responses and comments

1. Thank you for the revision. Table S2 provides an adequate overview of the framework.

Response: Thank you.

2. "The mention of the RE-AIM framework feels underdeveloped. If the authors are not applying it fully by reporting on key dimensions like reach, adoption, implementation, and maintenance, it may be better to omit the framework from the methodology or expand its use and provide relevant data for each component.

Response: Comment acknowledged. Since we did not report on all dimensions of the RE-AIM framework, we have removed it in this version."

Further comments:

In my opinion, if the authors do not expand on their use of the RE-AIM framework (specifying which components guided which indicators and acknowledging any components omitted due to limitations), they should consider mentioning other frameworks that may better suit the manuscript. Otherwise, readers may be confused about how each indicator was selected for analysis.

Response: Thank you again for the valid and valuable feedback. In this version, Table 1 has been substantially revised, with indicators mapped to the RE-AIM outcomes. Some outcome measures, such as Maintenance (sustainability), are not adequately measured and are addressed in the limitations section of the manuscript. See Pages 8-9, lines 157-159, and Table 1 pages 10-11, lines 193-197 as well as page 14, lines 230-234 on Revised Manuscript with Track Changes.

3. Fidelity should be clearly defined. Currently, it is discussed without specifying what

components of the intervention were monitored for adherence, or how deviations were

measured. A more structured discussion on how fidelity was evaluated would improve

the rigor of the paper.

Response: Comment acknowledged. In the measurement section, we have now

defined fidelity and outlined how we measured it, see Table 1 (page 10, line 188)

Further comments:

Thank you for defining fidelity. However, in line with the previous comment, the presentation of other indicators is confusing, as they don’t seem to clearly adhere to any specific framework.

For example, in the results section of the main text, the authors briefly mention fidelity with the statement: “Fidelity: A sizable progress in NoCs implementation fidelity was achieved.” Then, under the Fidelity subsection, functionality is reported instead: “The NoCs functionality score improved from 56% to 89% in agrarian settings and from 38% to 60% in pastoral settings (Fig 2). Improvements included enhanced coordination, standardized referral practices, and increased resource sharing among facilities. Coaching and mentorship strengthened at primary care levels, improving efficiency, access, and quality of care.”

This is confusing because the authors previously defined functionality as a separate indicator. Following a specific implementation evaluation framework (such as the RE-AIM framework or the MRC Process Evaluation Framework, https://pubmed.ncbi.nlm.nih.gov/25791983/) might clarify the structure and interpretation.

Response: As described above, in this version, fidelity is measured and defined by NoC functionality and maturity metrics, as well as by contextual challenges and adaptations in alignment with the RE-AIM framework. Table 1 pages 10-11, lines 193-197 on Revised Manuscript with Track Changes

4. “A summary table showing key indicators and the corresponding data collection

methods would be helpful for readers. This would clarify how the study measured

outcomes and tracked progress over time.

Response: Comment well taken and Table 1 presents the key indicators measured,

along with their definitions and data sources (page 10, line 183)”.

Further comments: See comments above.

Response: The indicators measured are presented in the revised Table 1, along with their definitions and data sources, in alignment with the RE-AIM framework. Table 1 pages 10-11, lines 193-197 on Revised Manuscript with Track Changes

Additional comments

1. Please avoid overusing abbreviations, as it can make the text difficult to understand. For example, "QI" should be written in full.

Response: Thank you for bringing this to our attention. In this version, we have removed abbreviations that are not frequently used in the text and written them out in full, including terms like QI, PDSA, FRAME-IS, ERIC, WDA, MOU, and EHCRIG.

2. Results (abstract)

“Results: The NoCs approach has significantly strengthened both administrative and technical connections, while enhancing relational linkages, multi-level collaboration, and bidirectional communication. This has fostered trust, improved care coordination, boosted primary health care performance, and increased health service utilization within woreda health systems. The Interrupted time series analysis indicated that the rate of ANC 8+ visits was 29.8% per month higher than expected without the NoCs strategy (Coef: 2.39; p-value < 0.01) and an 18.4% increase in obstetric complications managed (Coef: 1.71; p-value 36 = 0.050), with a 43% overall increase. Perinatal mortality decreased by 34%, from 31.3 to 20.1 per 1,000 births [t-test: 2.12; p-value: 0.040)].”

Could you clarify the definitions and distinctions between “administrative connections,” “technical connections,” “relational linkages,” “multi-level collaboration,” and “bidirectional communication”?

The results section in the main text reports different indicators than these terms. Could you explain the reason for this discrepancy? Furthermore, why does the abstract use a different format, such as “Implementation fidelity, challenges, and adaptations,” “Enhanced bidirectional linkages,” “Optimized HEP and improved performance and efficiency of the PHC system,” and “Improved utilization, quality, and continuity of care”?

Response: Thank you for the comments. We have revised the abstract (Results) section to provide greater clarity for readers as shown below.

“The NoCs approach has significantly enhanced relational linkages between primary health care facilities and health care providers, fostering stronger collaboration and communication. This has fostered trust, improved care coordination, optimized primary health care performance, and increased health service utilization within woreda health systems. The Interrupted time series analysis indicated that the rate of ANC 8+ visits was 29.8% per month higher than expected without the NoCs strategy (Coef: 2.39; p-value < 0.01) and an 18.4% increase in obstetric complications managed (Coef: 1.71; p-value = 0.050), with a 43% overall increase. Perinatal mortality decreased by 34%, from 31.3 to 20.1 per 1,000 births [t-test: 2.12; p-value: 0.040)].” See Pages 2-3, lines 31-40 on Revised Manuscript with Track Changes.

3. Discussions

“…Previous studies underscore that involving communities in these networks and quality improvement efforts significantly boosts maternal health program effectiveness. By engaging community members, local leaders, and stakeholders in service design, implementation, and evaluation, programs become more accessible, culturally sensitive, and widely utilized. Initiatives like participatory learning groups, community health committees, and training for health workers increase antenatal visits, skilled birth attendance, and postnatal care, ultimately lowering maternal and neonatal mortality rates [22-24]. These engaged networks build trust between health care providers and communities, ensuring interventions meet local needs sustainably.”

This section would benefit from additional references. For example, the statement “…Previous studies underscore that involving communities in these networks and quality improvement efforts significantly boosts maternal health program effectiveness” should be followed by citations that demonstrate the effectiveness of “involving communities in these networks…”

Response: Thank you 3 references are now included as suggested. Page 25, line 458 on Revised Manuscript with Track Changes

Additionally, the discussion section appears to emphasize the importance of the NOC framework without comparing other aspects of the research, such as fidelity, functionality, or the evaluation methodology, with existing literature. Please consider including these comparisons.

Response: Thank you for your valuable comments. In this version, we compared the use of implementation science research methodologies, bridging the knowledge gap left by previous studies focused on clinical experiences and case study descriptions. This study explored the mechanisms shaping networks between PHC facilities and communities. Additionally, we discussed how fidelity and adaptation influence implementation outcomes and addressed the limitations caused by inadequate fidelity and program implementation, particularly in assessing RE-AIM outcomes like Maintenance (sustainability). Page 26 lines 493-495; Page 27, lines 497-498; and lines 507-513 on Revised Manuscript with Track Changes

4. Please provide the study’s limitations.

Response: Thank you for the valid comment. The following paragraph is included in this version.

"Adapting programs to local contexts is crucial for ensuring strategies are both practical and effective. High-fidelity implementation improves PHC performance, health outcomes, and sustainability. However, due to the study’s limited duration, certain RE-AIM measures, such as sustainability (Maintenance), were not fully assessed, limiting the evaluation of NoCs’ maturity and integration into health system processes. Additionally, the absence of a comparison group may weaken the evidence from the time-series analysis, and the functionality and maturity matrix could be influenced by assessor bias and implementation variability." Page 27, lines 507-513 on Revised Manuscript with Track Changes

5. Please provide necessary information about the shared data in Supplementary #6.csv (e.g., brief descriptions, data dictionary).

Response: Apologies for overlooking the data dictionary. In this version, a data dictionary and brief description have been included as separate sheets labeled 'Data Dictionary' and 'Description.'

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Flora De Conto, Editor

Networks of Care for Optimizing Primary Health Care Service Delivery in Ethiopia: Enhancing Relational Linkages and Care Coordination

PONE-D-24-34411R2

Dear Dr. Tiruneh,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Flora De Conto, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Flora De Conto, Editor

PONE-D-24-34411R2

PLOS ONE

Dear Dr. Tiruneh,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Flora De Conto

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .